Since we hypothesized that the B55gamma-mediated inhibition of S6K activity contributed to the tolerance to glucose depletion in Glioma cells, we next tried to figure out whether exogenously expression of S6K in Glioma cell can potentially reverse the resistance to glucose depletion in U251B55gamma cells. This evidence concerns the gene RPS6KB1 and central nervous system cancer.